Skip to main content

Aviance Capital Partners, LLC

Position in NVO — Novo Nordisk A S

CIK 1542383 NAPLES, FL

Position in NVO

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$2,396,089
+$2,025,429 QoQ
Shares Held
49,981
+395.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#347
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Aviance Capital Partners, LLC holds $78,033,539 across 10 Drug Manufacturers - General names. NVO ranks #7 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
49,981 $2,396,089

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,396,089 49,981
2026-03-31 $370,660 10,086
2025-12-31 $518,365 10,188
2025-09-30 $593,077 10,688
2025-06-30 $3,131,368 45,369
2025-03-31 $803,490 11,571
2024-12-31 $995,337 11,571
2024-09-30 $2,035,025 17,091
2024-06-30 $2,329,659 16,321
2024-03-31 $2,083,033 16,223
2023-12-31 $1,573,060 15,206
2023-09-30 $928,133 10,206
2023-06-30 $1,149,478 7,103
2023-03-31 $1,130,371 7,103
2022-12-31 $1,096,660 8,103
2022-09-30 $408,781 4,103
2022-06-30 $457,197 4,103
2022-03-31 $455,638 4,103
2021-12-31 $459,536 4,103
2021-09-30 $393,929 4,103
2021-06-30 $343,708 4,103
2021-03-31 $238,734 3,541
2020-12-31 $247,338 3,541
2020-09-30 $245,851 3,541
2020-06-30 $231,864 3,541
2020-03-31 $213,168 3,541